Missouri Dangerous Drug Attorney

If you have experienced injuries or have lost a loved one because of a medication, contact Attorney Group for Missouri today to learn more about your options.

We offer free, confidential, no-obligation consultations. We can answer your questions, and if you wish to pursue a claim, we can connect you with an affiliated Missouri dangerous drug attorney who can assist you throughout the legal process.

Important: The time you have to pursue a claim is limited.

Call us at (314) 325-1818 today for your free case review.

See Our Full Directory

Search Lawsuits

How Does a Drug Reach the Market?

According to Drugs.com, over $12.6 billion is spent in the United States in researching and developing new drugs each year, and in order for a drug to reach the shelves, it must undergo a rigorous approval process. On average, the number of drugs that actually gain the approval of the U.S. Food and Drug Administration (FDA) for testing on humans is 1 in 1,000. Furthermore, the time spent to get the drug onto a shelf in a pharmacy takes approximately 12 years.

Prior to filing an application for human testing, prospective drugs must be tested extensively for nearly three years by their respective manufacturers in a laboratory. If the application is approved, a high degree of safety and effectiveness must be documented in three separate clinical trials.

Problems Facing the FDA Approval Process

According to an article published in Newsweek, there are several weak links in the approval process. Reportedly, there have been times when the FDA was aware of potentially deadly side effects, but still allowed a drug to reach the market. One instance involved a popular drug, named Tamiflu, which was hailed as one of the most effective anti-influenza drugs in existence.

This perspective quickly changed when investigators discovered that the makers of Tamiflu had hidden negative test results from over 70 different clinical trials. To make things worse, it was later revealed that the FDA was fully aware of Tamiflu’s potential side effects. This information was only revealed after the drug was distributed globally and reports of delirium, bipolar disorder, depression, and psychosis were documented in South Korea, the United States and Japan. Tamiflu’s manufacturer had also failed to publish over 100,000 pages of data. 

Clinical Studies and “Publication Bias”

In some cases, manufacturers may attempt to keep data from trials private so that negative aspects of the drug are not revealed. When manufacturers only release positive data, the action is known as publication bias. Over time, critics have pointed out that other important regulatory agencies do not have access to the same testing information as the FDA and pharmaceutical companies, despite all of the rigorous testing requirements for drugs. This may mean that patients do not have the whole picture concerning the drugs they are prescribed.

Fines and Penalties for Unethical Behavior

According to Natural News, in order to curb unethical behavior, the FDA imposes a variety of penalties and fines on drug companies each year. These cases included the antipsychotic drug Seroquel, which was illegally promoted for off-label use by its maker, AstraZeneca. The company was fined $520 million.  In 2011, after also being used for illegal off-label purposes, which were promoted by its maker, the drug Vioxx was linked to over 60,000 deaths caused by heart attacks. Its maker, Merck, was fined $950 million.

In a landmark case, GlaxoSmithKline, the makers of the antidepressants, Wellbutrin and Paxil, incurred a $3 billion fine for promoting the drugs for off-label uses. To date, this is the largest fine against a pharmaceutical company in American history. Other companies were penalized for deliberately making unproven claims in order to mislead the public and for refusing to publish studies that produced negative or inconclusive results. In all, pharmaceutical companies paid out over $7 billion in lawsuits, fines, and penalties between 2004 and 2010.

Why a Missouri Dangerous Drug Attorney May Be Necessary

Over the last several years, thousands of lawsuits have been filed by patients who claim that they were not informed of serious side effects such as uncontrolled bleeding, permanent hair loss, gastrointestinal problems, cancer, addictive behaviors and fetal defects. As a result, they say that they have suffered irreparable harm from the drugs and in many cases have struggled with physical embarrassment, additional medical costs, and emotional and mental pain. Because pharmaceutical companies may have financial and legal resources at their disposal, a Missouri dangerous drug attorney can help provide assistance to people who have been harmed by bad drugs.

How a Missouri Dangerous Drug Attorney Can Help

Drug makers have a duty to provide safe products. If there are risks of harm associated with their products, they also must provide adequate warnings. If a drug maker fails to fulfill this duty, it could be held liable in lawsuits for injuries that may result.

People injured by bad drugs may be eligible to recover money for:

  • Medical Expenses
  • Lost Wages
  • Pain and Suffering

The families of those who have died may be eligible to recover money for funeral expenses and the pain that comes with losing a loved one.

Top Bad Drugs

Missouri Abilify Lawsuit

Abilify has been allegedly linked to compulsive, pathological gambling, as well as other compulsive behaviors.

Learn More

Missouri Benicar Lawsuit

Some people who took Benicar claim to have experienced serious side effects such as severe gastrointestinal issues, including sprue-like enteropathy.

Learn More

Missouri Nexium Lawsuit

Some patients, however, claim that they later developed kidney disease or other serious health events after taking Nexium.

Learn More

Missouri Onglyza Lawsuit

Onglyza has been allegedly linked to severe side effects and health complications, including pancreatitis and pancreatic cancer.

Learn More

Missouri Taxotere Hair Loss Lawsuit

Taxotere has been linked to permanent hair loss in many patients, including women who suffered from breast cancer.

Learn More

Missouri Xarelto Lawsuit

Lawsuits allege that Xarelto manufacturer and marketer Bayer AG and Janssen have kept doctors and consumers in the dark about dangerous complications associated with the drug, including uncontrollable bleeding.

Learn More
View All Bad Drugs